Product
Plitidepsin
2 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Multicentre, Open Label, Randomised, Controlled, Basket, Pragmatic, Phase II, Clinical and Translational Study to Determine the Efficacy and Safety of Plitidepsin Versus Control in Immunocompromised Adult Patients With Symptomatic COVID-19 Requiring Hospital CareStatus: Terminated, Estimated PCD: 2024-03-19
Clinical trial
A Phase 3, Multicentre, Randomised, Controlled Trial to Determine the Efficacy and Safety of Two Dose Levels of Plitidepsin Versus Control in Adult Patient Requiring Hospitalisation for Management of Moderate COVID-19 InfectionStatus: Terminated, Estimated PCD: 2023-03-01